Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaneja Velenik

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Radiology and Oncology|September 30, 2017
Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian PopulationVaneja Velenik, Ajra Secerov-Ermenc, Jasna But-Hadzic, et al.
Croatian Medical Journal|October 17, 2006
Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trialVaneja Velenik, Franc Anderluh, Irena Oblak, et al.
Tumori|December 31, 2008
Radiotherapy for perianal Paget's disease: a case reportVaneja Velenik, Barbara Segedin, Franc Anderluh, et al.
Radiology and Oncology|June 27, 2013
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancerIrena Oblak, Vaneja Velenik, Franc Anderluh, et al.
Radiology and Oncology|October 19, 2012
Long term outcome after combined modality treatment for anal cancerIrena Oblak, Primoz Petric, Franc Anderluh, et al.
Radiology and Oncology|November 25, 2021
Preoperative intensity-modulated chemoradiotherapy with simultaneous integrated boost in rectal cancer: five-year follow-up results of a phase II studyJasna But-Hadzic, Anja Meden Boltezar, Tina Skerl, et al.
Radiology and Oncology|February 16, 2013
Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in SloveniaAna Jeromen, Irena Oblak, Franc Anderluh, et al.
Radiology and Oncology|July 4, 2014
Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinomaIrena Oblak, Marija Skoblar Vidmar, Franc Anderluh, et al.
Radiology and Oncology|August 31, 2012
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or IIIIrena Oblak, Franc Anderluh, Vaneja Velenik, et al.
Radiology and Oncology|June 2, 2015
Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancerIvica Ratosa, Irena Oblak, Franc Anderluh, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Radiology and Oncology|September 30, 2017
Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian PopulationVaneja Velenik, Ajra Secerov-Ermenc, Jasna But-Hadzic, et al.
Croatian Medical Journal|October 17, 2006
Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trialVaneja Velenik, Franc Anderluh, Irena Oblak, et al.
Tumori|December 31, 2008
Radiotherapy for perianal Paget's disease: a case reportVaneja Velenik, Barbara Segedin, Franc Anderluh, et al.
Radiology and Oncology|June 27, 2013
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancerIrena Oblak, Vaneja Velenik, Franc Anderluh, et al.
Radiology and Oncology|October 19, 2012
Long term outcome after combined modality treatment for anal cancerIrena Oblak, Primoz Petric, Franc Anderluh, et al.
Radiology and Oncology|November 25, 2021
Preoperative intensity-modulated chemoradiotherapy with simultaneous integrated boost in rectal cancer: five-year follow-up results of a phase II studyJasna But-Hadzic, Anja Meden Boltezar, Tina Skerl, et al.
Radiology and Oncology|February 16, 2013
Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in SloveniaAna Jeromen, Irena Oblak, Franc Anderluh, et al.
Radiology and Oncology|July 4, 2014
Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinomaIrena Oblak, Marija Skoblar Vidmar, Franc Anderluh, et al.
Radiology and Oncology|August 31, 2012
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or IIIIrena Oblak, Franc Anderluh, Vaneja Velenik, et al.
Radiology and Oncology|June 2, 2015
Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancerIvica Ratosa, Irena Oblak, Franc Anderluh, et al.
Pageof 4